EVERSANA is proud to sponsor the virtual 2021 Pharma/Biotech GTN Summit from November 17-19, 2021.
The GTN Summit is the foremost and longest-standing event for model-sharing on strategic forecasting, estimates, analytics and reporting for life science companies. Connect with EVERSANA and other industry leaders to discuss pharma and biotech best practices for GTN management, effective forecasts, enhanced visibility, profitability and control. Register here!
The application of clinical pathways and their enforcement through quality metric benchmark setting and appropriate use criteria is needed to guard against perverse financial incentives that encourage overutilization and underutilization. Moving forward, the more diligent payers and integrated delivery networks can be in evaluating and incorporating utilization criteria when establishing clinical pathways, the better off our system will be.
Download the latest white paper by revenue management expert Robert Blank to learn more about:
- Payer policies and market dynamics that can result in the overutilization or underutilization of healthcare treatments.
- Opportunities to mitigate the unintended consequences of previous policies, both through new Centers for Medicare & Medicaid Services policy efforts and clinical pathway application.
- How to moderate potential risks while confirming the operational capabilities necessary for success by assessing proposed contracting strategies.
At EVERSANA, we help you reduce revenue leakage, implement innovative contracting strategies and execute improved business processes that drive bottom-line impact. We leverage our deep expertise in the operational, technology and government compliance issues facing the industry to bring solutions ranging from business process outsourcing services, technology and data assets, and advisory services.